France Preventive Healthcare Technologies and service Market Market Report 2023 to 2030

France Preventive Healthcare Technologies and service Market Analysis

$ 3999

France Preventive Healthcare Technologies and Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Preventive Healthcare Technologies and Service is expanding as a result of rising incidence of chronic diseases and growing awareness among people. This demand is fueling the growth of Preventive Healthcare Technologies and Service market. Some of the key players in the global Preventive Healthcare Technologies and Service Market include Myriad Genetics, Inc., Quest Diagnostics Incorporated, Medtronic, Abbott, Merck & Co., GlaxoSmithKline plc, Omnicell, Inc., McKesson Corporation, Pfizer Inc., Dilon Medical Technologies, Inc., OMRON Healthcare Europe B.V., Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., and Sanofi.

ID: IN10FRHS091 CATEGORY: Healthcare Services GEOGRAPHY: France AUTHOR: Dr. Nensi Savani

Buy Now

France Preventive Healthcare Technologies and service Market Executive Summary

France Preventive Healthcare Technologies and service Market is valued at around $7.7 Bn in 2022 and is projected to reach $19.1 Bn by 2030, exhibiting a CAGR of 12% during the forecast period 2023-2030.

The government is putting more emphasis on healthcare as a result of an increase in the frequency of certain chronic and infectious diseases. Due to the growing burden, there have been more investments made in the construction of healthcare infrastructure. This is why digital healthcare technologies are preferred as they have demonstrated their effectiveness in improving the management of chronic diseases.

Healthcare IT benefits, which support long-term cost-effectiveness and make up for the high installation costs of today, should be made more widely known by the market for preventive healthcare technologies and services. As a result of the increased adoption of digital technologies, it is projected that the market for Preventive Healthcare Technology and Services would grow even more.

Firms like Myriad Genetics, Inc., Quest Diagnostics Incorporated, Medtronic, Abbott, Merck & Co., GlaxoSmithKline plc, Omnicell, Inc., McKesson Corporation, Pfizer Inc., Dilon Medical Technologies, Inc., OMRON Healthcare Europe B.V., Novx Systems, Corp., U-Systems, Ltd., Viatronix, Inc., and Sanofi, are some of the major players in the Preventive Healthcare Technologies and Service Market.

The adoption of supportive government policies to increase vaccination awareness through governmental and non-governmental organizations is boosting the global market for Preventive Healthcare Technologies and Services.

The demand for self-monitoring devices and technology advancements for healthcare systems is predicted to expand, which would boost the market for Preventive Healthcare Technologies and Services. But, since there aren't enough opportunities for patient interaction, doctors and chemists are less likely to use healthcare technology, restricting the market growth.

Market Dynamics

Drivers of France Preventive Healthcare Technologies and Service Market

Growing Incidence and Prevalence of Chronic Diseases: It has been established that preventive healthcare is successful in lowering the prevalence of chronic diseases. The demand for Preventative Healthcare Technologies and Services is anticipated to increase as the population ages.

Rising Healthcare Costs: Patients are becoming more interested in preventive treatment due to rising healthcare expenditures. To keep people healthy and lessen their financial strain, preventive healthcare is crucial. This is driving the market for Preventive Healthcare Technologies and Services.

Rising Awareness among People: The public's growing awareness of the prevalence of preventative measures to enhance the quality of life is fueling the Preventative Healthcare Technologies and Services market's expansion.

Developments in Preventive Healthcare Technologies and Service Market

In 2022, the AIG Hospital based in Hyderabad, India, announced the launch of new wellness centers that are solely aimed at revolutionizing preventive healthcare in India by increasing awareness about personalized and preventive medicines.

In 2022, GOQii Inc. raised USD10 Mn in an extended Series C Equity round of funding from Animoca Brands, which will be used to develop various offerings that leverage blockchain tokens and gamification in preventive healthcare.

In 2022, Healthlane launched the Healthlane App, a preventive healthcare technology that fosters comprehensive world-class medical care for longer and healthier lives.

Key players

Doctolib Withings Sanofi Orange Healthcare Cegedim Agfa-Gevaert Group Guerbet Group EOS imaging Implanet Mauna Kea Technologies

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Market Segmentations For France Preventive Healthcare Technologies and Service Market

By Type

Early Detection and Screening Technologies
Chronic Disease and Management Technologies
Vaccines
Advanced Technologies to Reduce Errors

By Application

Hospitals
Clinics
Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.